You are here

Article Text

Article menu
Download PDFPDF
Original research
Video laryngoscopy-assisted less-invasive surfactant administration quality improvement initiative
  1. Dalibor Kurepa1,
  2. Vitaliya Boyar2,
  3. Olena Predtechenska1,
  4. Venkata Gupta1,
  5. Barry Weinberger1,
  6. Margaret Pulju1,
  7. Alla Zaytseva1,
  8. Stephanie G Galanti1,
  9. Gangajal Kasniya1,
  10. Shahana Perveen2
  1. 1 Division of Neonatology, Cohen Children's Medical Center, New Hyde Park, New York, USA
  2. 2 Pediatrics, Cohen Children's Medical Center Division of Neonatology, New Hyde Park, New York, USA
  1. Correspondence to Dr Dalibor Kurepa, Division of Neonatology, Cohen Children's Medical Center, New Hyde Park, NY 11042, USA; dkurepa{at}northwell.edu

Abstract

Objective To describe the use of quality improvement methodology in transitioning from delivery of surfactant by INSURE (INtubation–SURfactant administration–Extubation) to video laryngoscope-assisted LISA (less-invasive surfactant administration) for infants with respiratory distress syndrome (RDS) receiving non-invasive ventilatory support.

Setting Two large neonatal intensive care units (NICUs) at Northwell Health (New Hyde Park, New York, USA).

Study population Infants with RDS receiving continuous positive airway pressure in the NICU and eligible for surfactant administration.

Results LISA was initiated in our NICUs in January 2021, after extensive guideline development, education programmes, hands-on training and provider credentialing. Our Specific, Measurable, Achievable, Relevant and Timely aim was to deliver surfactant by LISA for 65% of total doses by 31 December 2021. This goal was achieved within 1 month of go-live. In total, 115 infants received at least one dose of surfactant during the year. Of those, 79 (69%) received it via LISA and 36 (31%) via INSURE. Two Plan–Do–Study–Act cycles contributed to improved adherence to guidelines on timely surfactant administration and both written and video documentation.

Conclusions Safe and effective introduction of LISA with the use of video laryngoscopy is achievable with careful planning, clear clinical guidelines, adequate hands-on training and comprehensive safety and quality control.

  • neonatology
  • respiratory medicine

Data availability statement

Data are available in a public, open access repository. Data available in REDCap database upon request.

https://doi.org/10.1136/archdischild-2023-325357

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Data availability statement

    Data are available in a public, open access repository. Data available in REDCap database upon request.

    View Full Text

    Footnotes

    • Contributors DK proposed this study. All other authors worked with DK to design the study protocol. VG collected data and entered it into REDCap. DK, SP, BW, MP, VB, AZ, OP and SGG worked on data analysis and interpretation. All authors contributed to drafting of the manuscript and approved the final version. DK is responsible for the overall content as the guarantor.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.